Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
38%(3 trials)

Phase Distribution

Ph phase_1
2
25%
Ph phase_2
6
75%

Phase Distribution

2

Early Stage

6

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
6(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (25.0%)
Phase 26 (75.0%)

Trials by Status

completed8100%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_2

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT02443116
completedphase_2

Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)

NCT03912532
completedphase_2

A Study of NGM282 in Patients With Primary Sclerosing Cholangitis

NCT02704364
completedphase_1

Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals

NCT02649062
completedphase_2

Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis

NCT02026401
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02443116Phase 2

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

Completed
NCT03912532Phase 2

Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)

Completed
NCT02704364Phase 2

A Study of NGM282 in Patients With Primary Sclerosing Cholangitis

Completed
NCT02649062Phase 1

Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals

Completed
NCT02026401Phase 2

Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis

Completed
NCT02135536Phase 2

Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis

Completed
NCT01943045Phase 2

Phase 2 Study of NGM282 in Patients With Type 2 Diabetes

Completed
NCT01776528Phase 1

Phase 1 SAD and MAD Study of NGM282 in Healthy Adult Participants

Completed

All 8 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
8